<DOC>
	<DOCNO>NCT01928017</DOCNO>
	<brief_summary>This prospective observational clinical study characterise abnormality thromboelastography ( TEG ) parameters patient chemotherapy-induced thrombocytopenia . The investigator also study relationship Multiplate analysis bleed patient effect platelet transfusion thrombopoietin level percent reticulate platelet . The investigator ' hypothesis change TEG-parameters reflect patient tendency bleed .</brief_summary>
	<brief_title>Thromboelastography , Platelet Function Platelet Recovery Haemato-oncologic Patients With Thrombocytopenia</brief_title>
	<detailed_description>Thrombocytopenic patient follow blood sample ( thromboelastography , Multiplate , haematology ) daily , Monday Friday 30 day . In addition bleeding evaluation do daily , use standardized questionnaire . The questionnaire fill interview patient , som time next kin nurse . Nurse journal medical journal also use fill questionnaire . For thromboelastography ( TEG ) look parameter abnormal , factor platelet count influence result . We also compare TEG day without bleeding , see differ . For Multiplate pilot study see whether analysis use group patient . We look factor influence Multiplate result , see difference result patient bleeding . For reticulated platelet thrombopoietin study level relate platelet transfusion .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>Patients eligible study : They haematooncologic disease They , expect , thrombocytopenia They expect need least one platelet transfusion They age 18 year They consent participate Patients eligible study : They know congenital clot disorder They need anticoagulant regularly study period They immune thrombocytopenic purpura</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>